Breakthrough in Biotech: Purple Biotech Exceeds Expectations in Q2 2024 Earnings
Source: iQoncept / Shutterstock Purple Biotech (NASDAQ:PPBT) has recently released their outcomes for the second quarter of 2024. In an unexpected turn of events, Purple Biotech’s earnings per share stood at -9 cents, surpassing analysts’ projections of -18 cents. During the quarter, the company refrained from disclosing any revenue figures. Delving into historical contexts can ...












